Inventor · disambiguated record
Rémy Hanf
Also filed as: HANF REMY · HANF RÉMY
23 granted patents·9 pending applications·139 citations·filing 2007–2025
95Inventor score
Top patents by PatentIndex Score
32 records- 0198US11857523B2Methods of treatment of cholestatic diseasesGENFIT·Filed 2023·Granted Jan 2, 2024·7 cites·9 claims
- 0298US11850223B2Methods of treatment of cholestatic diseasesGENFIT·Filed 2023·Granted Dec 26, 2023·7 cites·10 claims
- 0398US11331292B2Methods of treatment of cholestatic diseasesGENFIT·Filed 2020·Granted May 17, 2022·13 cites·11 claims
- 0497US12295928B2Methods of treatment of cholestatic diseasesGENFIT·Filed 2023·Granted May 13, 2025·2 cites·26 claims
- 0597US12053445B2Methods of treatment of cholestatic diseasesGENFIT·Filed 2021·Granted Aug 6, 2024·7 cites·11 claims
- 0696US12310935B2Methods of treatment of cholestatic diseasesGENFIT·Filed 2023·Granted May 27, 2025·1 cites·28 claims
- 0796US12303480B2Methods of treatment of cholestatic diseasesGENFIT·Filed 2023·Granted May 20, 2025·1 cites·15 claims
- 0896US12295927B2Methods of treatment of cholestatic diseasesGENFIT·Filed 2023·Granted May 13, 2025·1 cites·26 claims
- 0996US12290498B2Methods of treatment of cholestatic diseasesGENFIT·Filed 2023·Granted May 6, 2025·1 cites·14 claims
- 1096US12233038B2Methods of treatment of cholestatic diseasesGENFIT·Filed 2023·Granted Feb 25, 2025·1 cites·24 claims
- 1193US11185519B2Methods of treatment of cholestatic diseasesGENFIT·Filed 2017·Granted Nov 30, 2021·15 cites·10 claims
- 1293US9221751B2Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disordersGENFIT·Filed 2014·Granted Dec 29, 2015·9 cites·21 claims
- 1392US8772342B2Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disordersDARTEIL RAPHAEL·Filed 2010·Granted Jul 8, 2014·39 cites·11 claims
- 1491US9585853B2Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disordersGENFIT·Filed 2015·Granted Mar 7, 2017·4 cites·15 claims
- 1590US9782373B2Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disordersGENFIT·Filed 2017·Granted Oct 10, 2017·3 cites·6 claims
- 1688US10350181B2Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disordersGENFIT·Filed 2018·Granted Jul 16, 2019·2 cites·19 claims
- 1788US8258182B2Substituted 1,3-diphenylpropane derivatives, preparations and uses thereofDELHOMEL JEAN-FRANCOIS·Filed 2007·Granted Sep 4, 2012·15 cites·9 claims
- 1886US8895619B2Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disordersGENFIT·Filed 2014·Granted Nov 25, 2014·8 cites·11 claims
- 1986US2025281437A1Methods of treatment of cholestatic diseasesGENFIT·Filed 2025·Application pending·0 cites
- 2077US8188148B2Substituted 1,3-diphenylpropane derivatives, preparations and uses thereofDELHOMEL JEAN-FRANCOIS·Filed 2007·Granted May 29, 2012·3 cites·7 claims
- 2169US10022343B2Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disordersGENFIT·Filed 2017·Granted Jul 17, 2018·0 cites·10 claims
- 2263US10792277B2Methods of treatment of fibrosis and cancersGENFIT·Filed 2017·Granted Oct 6, 2020·0 cites·23 claims
- 2359US10722575B2Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disordersGENFIT·Filed 2019·Granted Jul 28, 2020·0 cites·12 claims
- 2458US2024216313A1Elafibranor derivatives agonists of ppar for use in the treatment of sepsisGENFIT·Filed 2022·Application pending·0 cites
- 2558US2024216312A1Ppar-agonists for use in the treatment of liver failureGENFIT·Filed 2022·Application pending·0 cites
- 2658US2024238256A1Nitazoxanide in the treatment of sepsisGENFIT·Filed 2022·Application pending·0 cites
- 2757US2020384105A1Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disordersGENFIT·Filed 2020·Application pending·0 cites
- 2855US2024000754A1Methods of treatment of liver failureGENFIT·Filed 2021·Application pending·0 cites
- 2951US2015352065A1Methods of treatment of fibrosis and cancersGENFIT·Filed 2014·Application pending·0 cites
- 3048US2022241232A1Method for treatment of at risk patientsGENFIT·Filed 2020·Application pending·0 cites
- 3144US11519034B2Non-invasive diagnostic of non-alcoholic fatty liver diseases, non-alcoholic steatohepatitis and/or liver fibrosisGENFIT·Filed 2018·Granted Dec 6, 2022·0 cites·12 claims
- 3244US2020248261A1Non-invasive diagnostic of non-alcoholic fatty liver diseases, non-alcoholic steatohepatitis and/or liver fibrosisGENFIT·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Rémy Hanf files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →